Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Sloma

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Molecular Oncology|September 5, 2022
Evaluation of two new highly multiplexed PCR assays as an alternative to next-generation sequencing for IDH1/2 mutation detectionLoetitia Favre, Nouhoum Sako, Sihem Tarfi, et al.
Experimental Hematology|July 16, 2013
Genotypic and functional diversity of phenotypically defined primitive hematopoietic cells in patients with chronic myeloid leukemiaIvan Sloma, Philip A Beer, Kyi Min Saw, et al.
Molecular Oncology|May 28, 2022
High prevalence of unusual KRAS, NRAS, and BRAF mutations in POLE-hypermutated colorectal cancersLoetitia Favre, Justine Cohen, Julien Calderaro, et al.
Annals of Hematology|May 24, 2025
Subclonal emergence of polycythemia vera, chronic myelomonocytic leukemia, and chronic myeloid leukemiaViolaine Tran Quang, Jules Cretin, Romain Loyaux, et al.
Human Immunology|January 3, 2006
Early-onset ankylosing spondylitis is associated with a functional MICA polymorphismHabiba Amroun, Hachemi Djoudi, Marc Busson, et al.
Oncotarget|May 12, 2016
Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuationJean Claude Chomel, Marie-Laure Bonnet, Nathalie Sorel, et al.
Plos One|August 10, 2018
Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)Melanie Gentil, Patricia Hugues, Christophe Desterke, et al.
The Journal of Molecular Diagnostics : JMD|August 13, 2022
Fusion Gene Detection and Quantification by Asymmetric Capture Sequencing (aCAP-Seq)Guillaume Gricourt, Violaine Tran Quang, Jean-Michel Cayuela, et al.
Annales De Pathologie|September 1, 2022
[Myeloid neoplasms associated with rearrangement of PDGFRB: A rare and tricky disease]Christophe Bontoux, Bouchra Badaoui, Nassera Abermil, et al.
Blood|November 6, 2014
Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progressionPhilip A Beer, David J H F Knapp, Paul H Miller, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Molecular Oncology|September 5, 2022
Evaluation of two new highly multiplexed PCR assays as an alternative to next-generation sequencing for IDH1/2 mutation detectionLoetitia Favre, Nouhoum Sako, Sihem Tarfi, et al.
Experimental Hematology|July 16, 2013
Genotypic and functional diversity of phenotypically defined primitive hematopoietic cells in patients with chronic myeloid leukemiaIvan Sloma, Philip A Beer, Kyi Min Saw, et al.
Molecular Oncology|May 28, 2022
High prevalence of unusual KRAS, NRAS, and BRAF mutations in POLE-hypermutated colorectal cancersLoetitia Favre, Justine Cohen, Julien Calderaro, et al.
Annals of Hematology|May 24, 2025
Subclonal emergence of polycythemia vera, chronic myelomonocytic leukemia, and chronic myeloid leukemiaViolaine Tran Quang, Jules Cretin, Romain Loyaux, et al.
Human Immunology|January 3, 2006
Early-onset ankylosing spondylitis is associated with a functional MICA polymorphismHabiba Amroun, Hachemi Djoudi, Marc Busson, et al.
Oncotarget|May 12, 2016
Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuationJean Claude Chomel, Marie-Laure Bonnet, Nathalie Sorel, et al.
Plos One|August 10, 2018
Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)Melanie Gentil, Patricia Hugues, Christophe Desterke, et al.
The Journal of Molecular Diagnostics : JMD|August 13, 2022
Fusion Gene Detection and Quantification by Asymmetric Capture Sequencing (aCAP-Seq)Guillaume Gricourt, Violaine Tran Quang, Jean-Michel Cayuela, et al.
Annales De Pathologie|September 1, 2022
[Myeloid neoplasms associated with rearrangement of PDGFRB: A rare and tricky disease]Christophe Bontoux, Bouchra Badaoui, Nassera Abermil, et al.
Blood|November 6, 2014
Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progressionPhilip A Beer, David J H F Knapp, Paul H Miller, et al.
Pageof 3